Latest news about Caprolactam Chemicals
Caprolactam Chemicals
49.09
+2.32(+4.96%)
Company Performance:
View Company Insights1D+4.96%
1M+2.27%
6M0.00%
1Y+4.42%
5Y0.00%
More news about Caprolactam Chemicals
22Apr 26
Caprolactam Chemicals Ltd discloses non-applicability of Related Party Transaction regulations for FY26
Caprolactam Chemicals Ltd informed BSE that it is exempt from Related Party Transaction disclosures under Regulation 23(9) of SEBI LODR Regulations, 2015 for FY26, as its paid-up equity share capital of Rs. 4,60,00,000 and net worth of Rs. 4,95,89,569 as on March 31, 2025, are below the threshold limits of Rs. 10 crore and Rs. 25 crore respectively.
30Mar 26
Caprolactam Chemical Limited Announces Unanimous Approval of Postal Ballot Resolutions
Caprolactam Chemical Limited announced unanimous approval of all four postal ballot resolutions on 30th March, 2026. Each resolution received 82 votes representing 147487 shares with zero opposition votes. The approved measures include special resolutions for remuneration revisions of key executives Mr. Siddharth Shankarlal Bhanushali and Ms. Zaver Shankarlal Bhanushali, plus ordinary resolutions for related party transactions involving property leasing and consultancy fees.
30Mar 26
Caprolactam Chemicals Limited's 35th AGM Resolutions Receive Unanimous Shareholder Approval
Caprolactam Chemicals Limited's 35th AGM held on September 24, 2024, achieved unanimous approval for all four resolutions from 24 shareholders representing 2491005 votes. The resolutions included adoption of FY2024 financial statements, re-appointment of Mrs. Zaver Shankarlal Bhanushali as director, and appointment of two independent directors for five-year terms. Remote e-voting was conducted from September 19-23, 2024, under scrutinizer Rahul Gori's oversight, ensuring transparent and compliant voting procedures.
25Feb 26
Caprolactam Chemicals Limited Announces Postal Ballot Calendar for Director Remuneration and Related Party Transactions
Caprolactam Chemicals Limited has issued a postal ballot notice seeking shareholder approval for four resolutions including remuneration revisions for CFO Mr. Siddharth Bhanushali and MD Ms. Zaver Bhanushali, property leasing with Ms. Shital Bhanushali, and consultancy fee revision for Mr. Shankar Bhanushali. The e-voting process will run from February 28 to March 29, 2026.
27Jan 26
Caprolactam Chemicals Limited Schedules Board Meeting for February 13, 2026 to Review Q3FY26 Results and Dividend Recommendation
Caprolactam Chemicals Limited has scheduled its Board of Directors meeting for February 13, 2026, at 4:00 PM to consider and approve unaudited financial results for the quarter ended December 31, 2025, and evaluate dividend recommendations on equity shares. The company has implemented trading window restrictions for designated persons and their relatives, effective from January 1, 2026, until 48 hours after the financial results declaration, in compliance with insider trading regulations.
01Dec 25
Shital S. Bhanushali Increases Stake in Caprolactam Chemicals to 7.83%
Shital S. Bhanushali, a promoter of Caprolactam Chemicals Limited, has acquired 5,420 additional shares through an open market purchase. This acquisition has increased Bhanushali's total shareholding to 360,022 shares, representing 7.83% of the company. The transaction was completed on 28.11.2025 and reported in compliance with SEBI regulations.
25Sept 25
Caprolactam Chemicals Shareholders Approve Key Leadership Reappointments and New Auditor
Caprolactam Chemicals' 36th AGM saw shareholders approve several significant appointments. Ms. Zaver Shankarlal Bhanushali was reappointed as Managing Director for a five-year term from August 7, 2025, to August 6, 2030. Mr. Siddharth Shankarlal Bhanushali was reappointed as Whole Time Director and CFO for the same period. M/s. Alpi Nehra and Associates were appointed as Secretarial Auditors for five years. The Bhanushali family maintains strong leadership roles in the company, with Ms. Zaver being Mr. Siddharth's mother.
14Aug 25
Caprolactam Chemicals Reports Q1 FY26 Profit Turnaround and Announces 36th AGM Details
Caprolactam Chemicals Ltd. reported a turnaround in Q1 FY26 with a profit of ₹36.21 lakhs, compared to a loss in the previous quarter. Revenue increased by 59.4% to ₹256.47 lakhs. The company's 36th AGM is scheduled for September 25, 2025, with e-voting from September 20-24. The Board approved the Director's Report for FY25 and appointed scrutinizers for the e-voting process.
Industry Peers
Deepak Fertilisers & Petrochemicals
Tata Chemicals
Gujarat Narmada Valley Fert & Chem
TANFAC Industries
Gujarat Alkalies & Chemicals
GHCL
Grauer & Weil
Chemplast Sanmar
Fischer Medical Ventures
JG Chemicals
1,320.40
(-1.14%)
612.45
(+0.31%)
562.40
(-1.46%)
3,379.55
(-0.13%)
705.00
(-1.91%)
421.15
(-0.84%)
75.60
(-1.15%)
171.35
(-2.72%)
35.87
(+2.78%)
592.05
(-0.50%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
